Screener
Oric Pharmaceuticals, Inc. ORIC Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Research and development | $31,437 | $24,640 |
| General and administrative | 8,182 | 8,078 |
| Total operating expenses | 39,619 | 32,718 |
| Loss from operations | (39,619) | (32,718) |
| Other income, net | 3,852 | 2,697 |
| Net loss | $(35,767) | $(30,021) |
| Other comprehensive loss: | ||
| Unrealized loss on investments | (1,076) | (170) |
Item 1. Financial Statements.
FAQ
- What is Oric Pharmaceuticals, Inc.'s operating income?
- Oric Pharmaceuticals, Inc. (ORIC) reported operating income of -$39.62M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s operating income changed year-over-year?
- Oric Pharmaceuticals, Inc.'s operating income decreased by 21.1% year-over-year, from -$32.72M to -$39.62M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s operating income?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s operating income has grown at a 16.0% compound annual growth rate (CAGR), from -$78.87M to -$143M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Oric Pharmaceuticals, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude